RECRUITINGINTERVENTIONAL

Digital-supported Orofacial Myofunctional Therapy in OSA

Digital-supported Orofacial Myofunctional Therapy in Subjects With Obstructive Sleep Apnoea: A Pilot Randomised Control Trial

About This Trial

This pilot study explores the feasibility, acceptability, and preliminary effectiveness of Digital-supported Orofacial Myofunctional Therapy (d-MFT), an innovative program combining facial recognition technology with evidence-based orofacial exercises for individuals with mild to moderate obstructive sleep apnoea (OSA). The d-MFT program aims to strengthen oropharyngeal muscles, improve airway function, and reduce OSA severity. Participants receiving 3-month d-MFT (n=30) are expected to demonstrate greater improvements in OSA severity, sleep-related symptoms, and quality of life compared to those in the waitlist control group (n=30). Feasibility and acceptability will be evaluated through outcome-based questionnaires and semi-structured interviews to explore participants' experiences, satisfaction, and perceived barriers to adherence.

Who May Be Eligible (Plain English)

Who May Qualify: - Adults aged 18 years and above - Diagnosed with mild to moderate Obstructive Sleep Apnoea, defined as: Apnoea-Hypopnea Index of 5-30 events per hour - Indications for Continuous Positive Airway Pressure or oral appliance treatment, but unable to tolerate or decline these treatments - Body Mass Index less than 30 kg/m2 Who Should NOT Join This Trial: - Presence of obstructive nasal disease or significant nasal obstruction - Unstable mental health issues - History of stroke - Unstable chronic respiratory, cardiac, neurological conditions - Inability to provide willing to sign a consent form - Prior oral, pharyngeal, or maxillofacial surgical therapy for sleep apnoea Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Adults aged 18 years and above * Diagnosed with mild to moderate Obstructive Sleep Apnoea, defined as: Apnoea-Hypopnea Index of 5-30 events per hour * Indications for Continuous Positive Airway Pressure or oral appliance treatment, but unable to tolerate or decline these treatments * Body Mass Index less than 30 kg/m2 Exclusion Criteria: * Presence of obstructive nasal disease or significant nasal obstruction * Unstable mental health issues * History of stroke * Unstable chronic respiratory, cardiac, neurological conditions * Inability to provide informed consent * Prior oral, pharyngeal, or maxillofacial surgical therapy for sleep apnoea

Treatments Being Tested

BEHAVIORAL

Digital-supported Orofacial Myofunctional Therapy

The intervention include: (1) Five 30-minute d-MFT sessions; (2) two follow-up phone calls; and (3) facial and tongue exercise app for home practice.

Locations (1)

Queen Mary Hopsital

Hong Kong, Hong Kong, Hong Kong